Huge chance to innovate as online medical services take root, Platform makes name for...

Digital healthcare will play a major role in changing people's lives and health as the development of internet-based medical care in China grows, said...

Avance Clinical Client Immunic, Inc. Announced Dosing of First Healthy Volunteer in Phase 1...

The leading Australian CRO for biotechs and Frost & Sullivan 2020 Asia-Pacific CRO Market Leadership Award winner Avance Clinical is pleased to share the...

Regent Pacific enters longevity medicine business driven by leading AI technology through acquisition of...

Regent Pacific Group Limited ("Regent Pacific" or the "Company" and together with its subsidiaries, the "Group"; Hong Kong stock code: 00575), a specialist healthcare,...

Aptorum Group Announces Further Positive Data on ALS-4 against MRSA Wound Infection and MRSA...

Aptorum Group Limited (NASDAQ: APM, Euronext Paris: APM) ("Aptorum Group"), a biopharmaceutical company focused on novel therapeutics including the development of next-generation approach therapeutics...

Aptorum Group Announces Further Positive Data on SACT-1 Against Neuroblastoma and Other Potential Tumor...

Aptorum Group Limited (NASDAQ: APM, Euronext Paris: APM) ("Aptorum Group"), a biopharmaceutical company focused on the development of novel therapeutics including orphan diseases and...

Aptorum Group Limited Reports Financial Results and Business Update for the Six Months Ended...

Aptorum Group Limited (NASDAQ: APM, Euronext Paris: APM) ("Aptorum Group"or the "Company"), a biopharmaceutical company focuses on the development of novel therapeutics to address...

Junshi Biosciences Announces Financial Results for Six Months Ended June 30, 2020 and Provides...

-- Supplemental NDAs for Toripalimab filed -- Expanding into infectious disease and collaborating with IMCAS and Lilly for COVID-19 neutralizing antibodies -- Dual Listing on the...

Lee’s Pharm Announces 2020 Interim Results

Profit Attributable to the Owners of the Company Increased by 153.3% Actively Develop New Products Reform and Replenish the Sales Organisation Lee's Pharmaceutical Holdings Limited ("Lee's Pharm"...

Sihuan Pharmaceutical Launched an Equity Incentive Plan to Inject New Impetus for the Company’s...

Sihuan Pharmaceutical Holdings Group Ltd. (HKEX: 0460 "Sihuan Pharmaceutical" or the "Company", together with its subsidiaries, the "Group") announced that on 26 August 2020,...

Jacobson Pharma Collaborates with Fosun Pharma Group to Supply Potentially 10 Million Doses of...

Jacobson Pharma Corporation Limited ("Jacobson Pharma" or "the Group"; Stock Code: 2633.HK), a leading company engaged in the research, development, production, marketing and sale...

Universal Medical Announced its 2020 Interim Results

Maintained Steady Financial Performance under COVID-19 Pandemic Proceed with Hospital Group Business The board (the "Board") of directors (the "Directors") of Genertec Universal Medical Group Company...

Novotech the Asia-Pacific CRO Leader – Awarded ‘2020 Frost & Sullivan Asia-Pacific CRO Company...

Novotech, the largest biotech specialist CRO in the Asia-Pacific region, was awarded the '2020 Frost & Sullivan Asia-Pacific CRO Company of the Year' in...

Sihuan Pharmaceutical Announces 2020 Interim Results

Revenue and Profit Attributable to Owners of the Company from Continuing Operations are RMB1,054.5 million and RMB170.5 million, respectively; Multiple R&D and Production Platforms as...

Ivermectin Triple Therapy Protocol for COVID-19 Released to Australian GPs for Infected Elderly and...

Triple therapy specialist Professor Thomas Borody, famous for curing peptic ulcers using a triple antibiotic therapy saving millions of lives, today released the COVID-19...

AIM ImmunoTech提供2020年第二季度業務更新並報告COVID-19和癌症試驗進展

免疫藥物公司AIM ImmunoTech(NYSE- American 交易代碼: AIM) 是一家致力於研究治療免疫疾病,病毒性疾病和多種類型癌症的療法的免疫藥物公司,今天提供了截至2020年6月30日的第二季度業務和臨床前/臨床更新。 2020年第二季度財務摘要: - 截至2020年6月30日,AIM的現金,現金等價物和有價證券為4030萬美元,而截至2019年12月31日為880萬美元。 - 截至2020年6月30日的第二季度的研發費用為146萬美元,而截至2019年6月30日的第二季度的研發費用為110萬美元。 - 截至2020年6月30日的第二季度的一般和行政支出為172萬美元,而截至2019年6月30日的第二季度的194萬美元。 公司的2020年6月30日完整財務業績包含在於2020年8月14日提交給美國證券交易委員會的10-Q表內,該表格可從www.sec.gov和公司網站上獲得。 “ AIM致力於滿足COVID-19和癌症等關鍵未滿足的醫療需求的極其重要且具有開創性的臨床前和臨床研究,這為我們在廣闊的潛在市場中提供了“多重目標”。根據這些多種表現,AIM支持這些試驗的策略是最大限度地增加直接授予臨床站點的第三方,非稀釋性資金,是我們在許多試驗中均已完成的。此外,截至2020年6月30日,我們的資產負債表上有超過4,000萬美元的現金,現金等價物和有價證券。因此,我們相信,我們非常有能力執行未來的戰略,反過來,我們預計將為股東帶來可觀的價值。” AIM首席執行官Thomas K. Equels說。 COVID-19常規更新: - 在FDA於2020年5月11日批准IND後,AIM於2020年7月6日與Roswell Park 綜合癌症中心簽署了一項臨床試驗協議,以支持Roswell Park Ampligen與乾擾素alfa-2b聯合治療的1 / 2a期臨床試驗在患有COVID-19的癌症患者中,該疾病由SARS-CoV-2引起。該試驗有望很快開始患者入組。 - AIM與日本國立傳染病研究所和 Shionogi 公司簽署了三邊材料轉移和研究協議, Shionogi...

Bayer and Hua Medicine announce commercialization agreement and strategic partnership for investigational first-in-class novel...

- Investigational first-in-class glucokinase activator, with a novel mode of action, focused on fixing the glucose sensor and restoring glucose homeostasis for Type 2...

QBiotics Announces Clinical Collaboration with MSD Targeting Unresectable Melanoma

MSD collaboration to investigate QBiotics' lead molecule tigilanol tiglate in combination with KEYTRUDA(R) (pembrolizumab) Tigilanol tiglate is a novel, small molecule being developed...

China Medical System Holdings Limited 2020 Interim Results Announcement

Turnover (excl. the effect of "two-invoice system") up 4.6% to RMB3,557.1 Million; Profit up 11.4% to RMB1,300.5 Million; Continuous Expansion of Innovative Pipeline; Positive Progress Made in...

Epazz Engages PCAOB Auditor in Order to Uplist to the OTCQB; Releases Contact Tracing...

Epazz Engages PCAOB Auditor in Order to Uplist to the OTCQB; Releases Contact Tracing Update to DeskFlex for Covid-19 Back to School Epazz Inc. DeskFlex...

Milestone for Biowin’s Rapid COVID-19 Nucleic Acid Detector

Nasdaq-listed Shineco, Inc to acquire 73.7% stake in Changzhou Biowin Pharmaceutical Changzhou Biowin Pharmaceutical Co., Ltd. ("Biowin"), a Chinese biotech company focusing on diagnostic product...

Lotto Results

6/55 Grand Lotto Result Today and Past Results Summary from PCSO

METRO MANILA - Here is the PCSO 6/55 Grand Lotto Result Today. Check your lottery tickets and see if you’ve won 6/55 Grand Lotto...
6/55 Grand Lotto Result

6/55 Grand Lotto Result Today January 18, 2021 Monday PCSO

METRO MANILA - The Philippine Charity Sweepstakes Office (PCSO) is releasing the 6/45 Grand Lotto result tonight, January 18, 2021, Monday, at 9PM. PCSO releases...
Megalotto 6/45

6/45 MEGALOTTO RESULT Today and Previous Results From PCSO

Looking for the official 6/45 Megalotto result today? Here is the result of 6/45 Megalotto today based on the official draw of the Philippine...
Megalotto 6/45

PCSO 6/45 Megalotto Result Today Monday January 18, 2021

MANILA, Philippines - Megalotto 6/45 is one of the most popular six-digit, multi-million lottery games in the Philippines. Check your lotto ticket and see...
2D Lotto Big

2D Lotto Result Today and Previous Results from PCSO

Here are the 2D Ez2 Lotto result for today from the Philippine Charity Sweepstakes Office (PCSO). PCSO releases 2D Lotto results everyday during its...